Message from President
Message from President
YHLO JAPAN CO., LTD. was established on the 1st March 2022 in Tokyo as a 'Research and Development Centre.'
Aiming to achieve 'World-Class Quality,' we operate under the slogan 'From China to the World.'
Corporate Profile
| Company Name | YHLO JAPAN CO., LTD. |
|---|---|
| Address | 1-22-13 Akebonocho, Tachikawa-shi, Tokyo 190-0012 |
| Representative | WATANABE Haruhisa, Representative Director & President |
| Established | March 2022 |
| Capitalisation | 100 Million Japanese Yen |
| Number of Employees | 30 (as of January 2025) |
| Business Description | Research and development of automated specimen analysis instrument as of fiscal year ended December 2023 |
Corporate History
| March 2022 |
Established in Hachioji, Tokyo with 2 employees. |
|---|---|
|
July 2022 |
Relocated to Tachikawa,
Tokyo with 4 employees. |
|
March 2023 |
Moved to a new office in Tachikawa, Tokyo with 11 employees |
| January 2025 |
Expanded to 30 employees. |
About the Shenzhen Corporate Office
Shenzhen YHLO Biotech Co., Ltd. is one of the leaders in the field of clinical diagnostics. Established in 2008 and headquartered in Shenzhen, China, YHLO is a rapidly growing company specialising in the development and manufacturing of clinical diagnostic instrument and reagents. In 2021, YHLO was publicly listed on the Shanghai Stock Exchange, marking a significant milestone in its history.
Further expanding YHLO’s global footprint, YHLO JAPAN was established in 2022 as our dedicated research and development centre. This subsidiary, a wholly-owned entity of YHLO, independently manages its operations with a primary focus on pioneering research and development. YHLO JAPAN not only supports but leads the research initiatives across our network, enhancing YHLO’s overall capabilities in product quality and advancing its reach into global markets.
YHLO is committed to innovation and excellence, driving forward with its mission to deliver world-class quality in clinical diagnostics.
